~~<i id='956E04CC37'><strike id='956E04CC37'><tt id='956E04CC37'><pre id='956E04CC37'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：comprehensive 2025-09-06 03:33:04 - browse：92839

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The lessons of Aduhelm, an Alzheimer's drug that was not to be

explore

focus

Wikipedia

focus

explore

hotspot

Rep.BradWenstrup(R-Ohio)AnnaMoneymaker/GettyImagesWASHINGTON—HouseRepublicanshaverepeatedlyaccusedBi

WSS

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Grail faces three suits alleging harassment, retaliation

Juul spent big to court Black leaders to promote its e

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Can CDC director Mandy Cohen drive consensus in Washington?

Federal judge rules Oregon’s tough new gun law is constitutional

focus

leisure time

explore

The high cost of giving birth even with insurance

Argenx drug significantly slows progression of nerve disorder

Tori Bowie and the unacceptable rates of Black maternal death

Congress likely to miss an opportunity to fix drug shortages issue

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Celiac disease study examines precisely how gluten triggers injury

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why police arrested suspected Gilgo Beach killer away from his house

Anesthesiologist group: stop taking Ozempic before surgery

Congress likely to miss an opportunity to fix drug shortages issue

focus

Can CDC director Mandy Cohen drive consensus in Washington?

Covid misinformation case heads to Supreme Court

Argenx drug significantly slows progression of nerve disorder

The real point of Kenneth Smith’s execution by nitrogen gas

Juul spent big to court Black leaders to promote its e

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Wikipedia

focus

explore

hotspot